DHR vs V: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Visa Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
Visa Inc. · Financial Services
$368.29
+25.7% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
V |
| Current Price |
$221.12 |
$368.29 |
| Fair Value Estimate |
$286.52 |
$463.00 |
| Upside to Fair Value |
+29.6%
|
+25.7%
|
| Market Cap |
$155.4B |
$687.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
24.0x
|
| Price / Sales |
6.2x
|
15.5x
|
| Price / FCF |
28.5x
|
33.5x
|
| Revenue Growth YoY |
+5.5%
|
+14.4%
|
| Gross Margin |
58.5%
|
80.2%
|
| Operating Margin |
20.4%
|
60.7%
|
| Return on Equity |
7.7%
|
61.3%
|
| Dividend Yield |
0.65% |
0.73% |
| FCF Yield |
3.51%
|
2.98%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
Visa operates the world's largest retail payments network, connecting consumers, merchants, issuers, and acquirers through VisaNet, which authorizes, clears, and settles transactions across more than 200 countries. The business quality is exceptional: TTM gross margin of 80.2%, operating margin of 60.7%, net margin of 50.8%, and ROE of 61.3% reflect a two-sided network with powerful scale economi…
Accumulation Zones
| Metric |
DHR |
V |
| Zone Low |
$214.89 |
$347.25 |
| Zone High |
$243.54 |
$393.55 |
| In Buy Zone? |
Yes
|
Yes
|